Company profile: enVVeno Medical
1.1 - Company Overview
Company description
- Provider of bioprosthetic devices for cardiovascular surgeries, including VenoValve, a surgically implanted one-way valve to restore proper blood flow in the femoral vein for patients with deep venous Chronic Venous Insufficiency (CVI), and enVVe, a non-surgical, transcatheter-based replacement venous valve for minimally invasive treatment of CVI in the deep veins of the leg.
Products and services
- Bioprosthetic Cardiovascular Device Development: Engineers bioprosthetic devices for cardiovascular surgeries, targeting venous valve restoration for deep venous CVI in the femoral and deep leg veins
- EnVVe: A non-surgical, transcatheter-based replacement venous valve engineered for minimally invasive implantation to treat CVI in the deep veins of the leg
- VenoValve: A surgically implanted one-way valve constructed to restore proper blood flow in the femoral vein for patients with deep venous CVI
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to enVVeno Medical
Devax
HQ: United States
Website
- Description: Provider of medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Devax company profile →
BioVentrix
HQ: United States
Website
- Description: Provider of medical devices and clinical programs for congestive heart failure: the Revivent TC TransCatheter Ventricular Enhancement System to reshape the left ventricle and improve function by excluding scarred tissue using micro-anchor implants; the ALIVE clinical study for LV scarring; NYHA III–IV patient identification criteria and training; and an educational resource library.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioVentrix company profile →
Millipede Medical
HQ: United States
Website
- Description: Provider of a percutaneous, catheter-based solution for mitral valve repair and treatment of mitral and tricuspid regurgitation, restoring health and expanding options for physicians and patients globally.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millipede Medical company profile →
GENinCode
HQ: United Kingdom
Website
- Description: Provider of genetic testing solutions for cardiovascular disease risk assessment and prediction, combining genetic and clinical data to guide patient evaluation. Offerings include CARDIO inCode-Score for coronary heart disease, LIPID inCode for hyperlipidemia and familial hypercholesterolemia, SUDD inCode for sudden cardiac death, THROMBO inCode for venous thromboembolism, ROCA for ovarian cancer, and SITAB web portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GENinCode company profile →
Axovan
HQ: Switzerland
Website
- Description: Provider of drug development specializing in G protein-coupled receptors, based in Switzerland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axovan company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for enVVeno Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to enVVeno Medical
2.2 - Growth funds investing in similar companies to enVVeno Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for enVVeno Medical
4.2 - Public trading comparable groups for enVVeno Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →